The following presentations were recorded during the 2016 Medical Symposium located in Paris, France at Hôpital Pitié-Salpêtrière.  We are pleased to have this information to share with those that were not able to attend the meetings or that wanted to recapture some of the information shared.  Thank you to the speakers that volunteered their time and information. Thanks also to the volunteers and staff that were able to create and edit the videos for all to view.

Visit the ECD Global Alliance YouTube channel for all published ECD related videos.

Presenter  Presentation Slides Videos
Corrado Campochiaro, MD Management of ECD Symptoms and Side Effects of Treatments Management of ECD Symptoms and Side Effects of Treatments 
Giulio Cavalli, MD Adult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester Disease Adult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester Disease
Carine Courtillot, MD Endocrine manifestations in Erdheim-Chester disease Endocrine manifestations in Erdheim-Chester disease
Benjamin Durham, MD Insights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine Models Insights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine Models
Marina Ferrarini, MD Tailoring Treatment for Erdheim-Chester Disease: Focus on ECD Tailoring Treatment for Erdheim-Chester Disease: Focus on ECD
Ronald Go, MD Efficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD) Efficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD)
Filip Janku, MD, PhD Encouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation status

Clinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester Disease

Encouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation status

Clinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester Disease

Javier Martin, MD, PhD Future Genetic Studies in Erdheim-Chester disease – GWAS Study Future Genetic Studies in Erdheim-Chester disease – GWAS Study
Kenneth McClain, MD, PhD Elevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD? Elevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD?
Augusto Vaglio, MD, PhD MRI evidence of cardiac involvement in Erdheim-Chester disease MRI evidence of cardiac involvement in Erdheim-Chester disease

See also the summary of presentations and information on the next ECD Medical Symposium.

Contact Us

  • ECD Global Alliance, P.O. Box 775,
    DeRidder, LA 70634 USA

Featured Partners

Copyright 2017. All rights Reserved ECD GLOBAL ALLIANCE. A 501(c)(3) organization